GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹241 Cr | ₹187 Cr | ₹137 Cr | ₹98 Cr | ₹71 Cr |
What is the latest Total Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹241 Cr |
Mar2023 | ₹187 Cr |
Mar2022 | ₹137 Cr |
Mar2021 | ₹98 Cr |
Mar2020 | ₹71 Cr |
How is Total Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹241 Cr | 29.13 | |
Mar2023 | ₹187 Cr | 36.30 | |
Mar2022 | ₹137 Cr | 39.37 | |
Mar2021 | ₹98 Cr | 38.41 | |
Mar2020 | ₹71 Cr | - |
Compare Total Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,552.9 Cr | -0.6% | 9% | 156.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -0.6% |
9% |
156.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses